Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, et al. Prostate cancer screening in the Tyrol, Austria: Experience and results. Eur J Cancer 2000;36: 1322-35.Horninger W, Reissigl A, Rogatsch H, et al. Prostate cancer screening in Tyrol, Austria: experience...
Mass ScreeningNeoplasm StagingEarly Detection of CancerDisease ManagementMaleBackground: Assessment and management of symptoms is a main task in primary care. Symptoms may be defined as 'any subjective evidence of a health problem as perceived by the patient'. In other words, symptoms do not ...
The Medical journal of AustraliaDonovan JL, Hamdy FC, Neal DE. "Screening for prostate cancer. The case against." Prostate-Testing for Cancer and Treatment study group. Ann R Coll Surg Engl, 2005; 87(2): 90-1.Hirst GH, Ward JE, Del Mar CB. Screening for prostate cancer: the case ...
Self-reported,screening,AustriaObjectives: The prevalence of self-reported participation and frequency of prostate cancer screening (digital rectal examination (DRE), prostate-specific antigen (PSA)) in Austrian men aged 40–79 years in the year 2005 is reported.Christian Vutuc, Thomas Waldhoer, ...
Australia 6Familial Cancer Centre, Royal Melbourne Hospital, Grattan St, Parkville, Victoria, 3050, Australia Key words: BRCA1, BRCA2, prostate, screening Corresponding author: Kelly-Anne Phillips, Dept of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St...
Measurement of selenium in the blood or in tissues (such as toenail clippings) to assess the risk of developing prostate cancer because it has no proven value for this indication; The following for prostate cancer screening because they have no proven value for this indication (not an all-inclu...
Prostate cancer screening Oncolog-HematologEnchescu, CiprianKhouchani, Mouna
“Mass Screening”, “Early Detection of Cancer”, “Diagnosis”) and as free search terms (“guideline”, “prostate cancer”, “prostate specific antigen”, “screening”, “diagnosis”). Guidelines published since 2008 were included in this study. The most updated version of these CPGs was...
Is screening—an important means of cancer control for many sites—a reasonable approach for prostate cancer control? The answer is not straightforward because prostate cancer is not one, but three diseases: a latent form which will cause no harm; a progressive form which will become symptomatic ...
Prostate-Specific Antigen–Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05229-EF-1. 4. Fenton JJ, Weyrich MS, Durbin ...